Beyond the well-characterized autocrine/paracrine activating actions ofHRG on the erbB network-driven signaling, its intracrine regulation of telomere-dependent genome stability may provide a key rate-limiting stepin breast carcinogenesis and metastatic progression. The gene discussed is EGFR; the disease is medical procedure.